Download
12931_2024_Article_2961.pdf 3,19MB
WeightNameValue
1000 Titel
  • Tobacco and COPD: presenting the World Health Organization (WHO) Tobacco Knowledge Summary
1000 Autor/in
  1. Lu, Wenying |
  2. Aarsand, Rebekka |
  3. Schotte, Kerstin |
  4. Han, Jing |
  5. Lebedeva, Elizaveta |
  6. Tsoy, Elena |
  7. Maglakelidze, Nino |
  8. Soriano, Joan B |
  9. Bill, Werner |
  10. Halpin, David M G |
  11. Rivera, M. Patricia |
  12. Fong, Kwun M |
  13. Kathuria, Hasmeena |
  14. Yorgancıoğlu, Arzu |
  15. Gappa, Monika |
  16. Lam, David CL |
  17. Rylance, Sarah |
  18. Sohal, Sukhwinder Singh |
1000 Verlag BioMed Central
1000 Erscheinungsjahr 2024
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2024-09-11
1000 Erschienen in
1000 Quellenangabe
  • 25(1):338
1000 Copyrightjahr
  • 2024
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1186/s12931-024-02961-5 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11391604/ |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • The WHO recently published a Tobacco Knowledge Summary (TKS) synthesizing current evidence on tobacco and COPD, aiming to raise awareness among a broad audience of health care professionals. Furthermore, it can be used as an advocacy tool in the fight for tobacco control and prevention of tobacco-related disease. This article builds on the evidence presented in the TKS, with a greater level of detail intended for a lung-specialist audience. Pulmonologists have a vital role to play in advocating for the health of their patients and the wider population by sharing five key messages: (1) Smoking is the leading cause of COPD in high-income countries, contributing to approximately 70% of cases. Quitting tobacco is an essential step toward better lung health. (2) People with COPD face a significantly higher risk of developing lung cancer. Smoking cessation is a powerful measure to reduce cancer risk. (3) Cardiovascular disease, lung cancer and type-2 diabetes are common comorbidities in people with COPD. Quitting smoking not only improves COPD management, but also reduces the risk of developing these coexisting conditions. (4) Tobacco smoke also significantly impacts children's lung growth and development, increasing the risk of respiratory infections, asthma and up to ten other conditions, and COPD later in life. Governments should implement effective tobacco control measures to protect vulnerable populations. (5) The tobacco industry's aggressive strategies in the marketing of nicotine delivery systems and all tobacco products specifically target children, adolescents, and young adults. Protecting our youth from these harmful tactics is a top priority.
1000 Sacherschließung
lokal Pulmonary Disease, Chronic Obstructive/prevention
lokal Pulmonary Disease, Chronic Obstructive/epidemiology [MeSH]
lokal Chronic obstructive pulmonary disease
lokal Humans [MeSH]
lokal Smoking/epidemiology [MeSH]
lokal Smoking cessation
lokal World Health Organization [MeSH]
lokal Smoking/adverse effects [MeSH]
lokal Tobacco control
lokal Health Knowledge, Attitudes, Practice [MeSH]
lokal Smoking Cessation [MeSH]
lokal Smoking
lokal Review
1000 Fächerklassifikation (DDC)
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/THUsIFdlbnlpbmc=|https://frl.publisso.de/adhoc/uri/QWFyc2FuZCwgUmViZWtrYQ==|https://frl.publisso.de/adhoc/uri/U2Nob3R0ZSwgS2Vyc3Rpbg==|https://frl.publisso.de/adhoc/uri/SGFuLCBKaW5n|https://frl.publisso.de/adhoc/uri/TGViZWRldmEsIEVsaXphdmV0YQ==|https://frl.publisso.de/adhoc/uri/VHNveSwgRWxlbmE=|https://frl.publisso.de/adhoc/uri/TWFnbGFrZWxpZHplLCBOaW5v|https://frl.publisso.de/adhoc/uri/U29yaWFubywgSm9hbiBC|https://frl.publisso.de/adhoc/uri/QmlsbCwgV2VybmVy|https://frl.publisso.de/adhoc/uri/SGFscGluLCBEYXZpZCBNIEc=|https://frl.publisso.de/adhoc/uri/Uml2ZXJhLCBNLiBQYXRyaWNpYQ==|https://frl.publisso.de/adhoc/uri/Rm9uZywgS3d1biBN|https://frl.publisso.de/adhoc/uri/S2F0aHVyaWEsIEhhc21lZW5h|https://frl.publisso.de/adhoc/uri/WW9yZ2FuY8Sxb8SfbHUsIEFyenU=|https://frl.publisso.de/adhoc/uri/R2FwcGEsIE1vbmlrYQ==|https://frl.publisso.de/adhoc/uri/TGFtLCBEYXZpZCBDTA==|https://frl.publisso.de/adhoc/uri/UnlsYW5jZSwgU2FyYWg=|https://frl.publisso.de/adhoc/uri/U29oYWwsIFN1a2h3aW5kZXIgU2luZ2g=
1000 Hinweis
  • DeepGreen-ID: 4026838dd55c4d90baf034879f63f7de ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search) ;
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6521745.rdf
1000 Erstellt am 2025-07-06T10:04:13.156+0200
1000 Erstellt von 322
1000 beschreibt frl:6521745
1000 Zuletzt bearbeitet 2025-08-04T09:51:35.532+0200
1000 Objekt bearb. Mon Aug 04 09:51:35 CEST 2025
1000 Vgl. frl:6521745
1000 Oai Id
  1. oai:frl.publisso.de:frl:6521745 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source